Tong Sun Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2023	NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity.
12/2022	The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review.
2/2022	Tetramethylpyrazine alleviates diabetes-induced high platelet response and endothelial adhesion via inhibiting NLRP3 inflammasome activation.
1/2020	Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes.
1/2020	HRD1, an Important Player in Pancreatic β-Cell Failure and Therapeutic Target for Type 2 Diabetic Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong Sun Research Topics

Disease

57	Neoplasms (Cancer) 05/2024 - 05/2002
16	Prostatic Neoplasms (Prostate Cancer) 03/2018 - 04/2009
13	Infections 11/2023 - 03/2016
13	Carcinogenesis 01/2022 - 08/2005
11	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2005
9	Breast Neoplasms (Breast Cancer) 03/2024 - 03/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2006
9	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2006
7	Inflammation (Inflammations) 01/2023 - 07/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 10/2009
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2020
5	Stomach Neoplasms (Stomach Cancer) 10/2019 - 11/2004
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 07/2005
4	Myopia 01/2023 - 02/2010
4	7 Hereditary Prostate Cancer 05/2016 - 07/2010
4	Leukemia 01/2016 - 03/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2024 - 02/2022
3	Carcinoma (Carcinomatosis) 11/2023 - 05/2002
3	Obesity 01/2023 - 12/2006
3	Philadelphia Chromosome 01/2016 - 03/2003
2	Osteosarcoma (Osteogenic Sarcoma) 05/2024 - 01/2024
2	Virus Diseases (Viral Diseases) 11/2023 - 01/2023
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 08/2021
2	Neuroinflammatory Diseases 08/2023 - 01/2023
2	Parkinson Disease (Parkinson's Disease) 08/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 09/2020
2	Presbyopia 01/2023 - 01/2022
2	Atherosclerosis 01/2023 - 09/2022
2	Body Weight (Weight, Body) 10/2022 - 11/2007
2	Adenocarcinoma 08/2022 - 08/2005
2	COVID-19 01/2022 - 01/2021
2	Normal Pressure Hydrocephalus 08/2021 - 01/2019
2	Stroke (Strokes) 01/2021 - 01/2020
2	Hydrocephalus (Hydrocephaly) 01/2021 - 07/2020
2	Hypertrophy 11/2019 - 12/2006

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2002
8	Long Noncoding RNAIBA 01/2022 - 03/2016
6	Biomarkers (Surrogate Marker)IBA 05/2024 - 05/2008
6	ORALIT (ORS)IBA 11/2023 - 12/2006
5	MicroRNAs (MicroRNA)IBA 03/2024 - 08/2009
5	6-methyladenineIBA 01/2023 - 01/2020
5	Hormones (Hormone)IBA 11/2019 - 05/2002
4	Peptides (Polypeptides)IBA 05/2024 - 12/2006
4	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 09/2019
4	Circular RNAIBA 01/2023 - 06/2019
4	LigandsIBA 07/2016 - 07/2004
4	AndrogensIBA 12/2011 - 04/2009
3	SeleniumIBA 01/2024 - 01/2016
3	NucleotidesIBA 08/2023 - 05/2007
3	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2020
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 07/2010
3	N-methyladenosineIBA 01/2022 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 04/2021 - 01/2016
3	Therapeutic UsesIBA 04/2021 - 05/2002
3	Messenger RNA (mRNA)IBA 12/2020 - 11/2007
3	fas Receptor (CD95 Antigen)IBA 05/2020 - 07/2004
3	Caspase 8 (Caspase-8)IBA 05/2020 - 05/2007
3	Oncogene Proteins (Oncogene Protein)IBA 10/2019 - 01/2006
3	EnzymesIBA 09/2019 - 03/2007
3	Androgen Receptors (Androgen Receptor)IBA 03/2018 - 01/2014
3	Matrix Metalloproteinases (MMPs)IBA 02/2012 - 03/2004
3	prolyl-proline (Pro-Pro)IBA 07/2008 - 01/2006
3	Fas Ligand Protein (Fas Ligand)IBA 05/2008 - 07/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2007 - 04/2006
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2005 - 03/2004
2	PotassiumIBA 12/2024 - 01/2023
2	ElementsIBA 05/2024 - 01/2024
2	Durapatite (Hydroxylapatite)IBA 05/2024 - 01/2024
2	polycaprolactoneIBA 05/2024 - 01/2024
2	StrontiumIBA 01/2024 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2024 - 01/2020
2	Oxygen (Dioxygen)IBA 12/2023 - 01/2021
2	InterleukinsIBA 08/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Cadherins (E-Cadherin)IBA 01/2023 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2005
2	InterferonsIBA 01/2023 - 09/2020
2	IronIBA 01/2023 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 04/2020
2	phytobacteriomycin (PBM)IBA 01/2022 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2004
2	polyetheretherketoneIBA 07/2020 - 04/2018
2	TitaniumIBA 07/2020 - 04/2018
2	Death Domain ReceptorsIBA 05/2020 - 05/2007
2	Phosphotransferases (Kinase)IBA 05/2020 - 11/2004
2	apatinibIBA 01/2020 - 01/2019
2	Tyrosine (L-Tyrosine)FDA Link 10/2019 - 10/2002
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2019 - 05/2016

Therapy/Procedure

17	Therapeutics 05/2024 - 04/2009
10	Drug Therapy (Chemotherapy) 05/2024 - 06/2004
5	Immunotherapy 12/2023 - 01/2014
3	Ventriculoperitoneal Shunt 08/2021 - 07/2020
3	Castration 03/2018 - 04/2009
2	Intraocular Lenses (Intraocular Lens) 10/2022 - 01/2022
2	Laser In Situ Keratomileusis (LASIK) 04/2022 - 02/2010
2	Lasers (Laser) 04/2022 - 02/2010
2	Catheters 01/2022 - 01/2019
2	Low-Level Light Therapy (LLLT) 01/2022 - 01/2020
2	Thrombolytic Therapy 01/2022 - 01/2021